1st Quarter - Report

PRIME THERAPEUTICS for PRIME THERAPEUTICS

Period 1st Quarter 2009 Filed Apr 20, 2009 Signed by Jerome L. Steffl, VP, Government Affairs

Official filing
Firm
PRIME THERAPEUTICS
Client
PRIME THERAPEUTICS
Income
—
Expenses
$106,702
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Insurance INS

HR 1/S 1 "American Recovery and Reinvestment Act of 2009" (COBRA, health information technology, privacy, comparative effectiveness research) HR 1204 "Community Pharmacy Fairness Act of 2009" HR 1427 "Promoting Innovation and Access to Life-Saving Medicine Act" S 726 "Promoting Innovation and Access to Life-Saving Medicine Act" HR 1548 "Pathway for Biosimilars Act" Health Care Reform (health information technology, electronic prescribing, public health plans, comparative effectivness research, generic pharmaceuticals) Medicare Part D

LobbyistCovered position, as disclosed
JERRY STEFFL —

Contacted: Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 1427 (111th), H.R. 1 (111th), H.R. 1204 (111th), H.R. 1548 (111th)

Health Issues HCR

HR 1/S 1 "American Recovery and Reinvestment Act of 2009" (COBRA, health information technology, privacy, comparative effectiveness research) HR 1204 "Community Pharmacy Fairness Act of 2009" HR 1427 "Promoting Innovation and Access to Life-Saving Medicine Act" S 726 "Promoting Innovation and Access to Life-Saving Medicine Act" HR 1548 "Pathway for Biosimilars Act" Health Care Reform (health information technology, electronic prescribing, public health plans, comparative effectivness research, generic pharmaceuticals) Medicare Part D

LobbyistCovered position, as disclosed
JERRY STEFFL —

Contacted: Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 1427 (111th), H.R. 1548 (111th), H.R. 1204 (111th), H.R. 1 (111th)

Pharmacy PHA

HR 1/S 1 "American Recovery and Reinvestment Act of 2009" (COBRA, health information technology, privacy, comparative effectiveness research) HR 1204 "Community Pharmacy Fairness Act of 2009" HR 1427 "Promoting Innovation and Access to Life-Saving Medicine Act" S 726 "Promoting Innovation and Access to Life-Saving Medicine Act" HR 1548 "Pathway for Biosimilars Act" Health Care Reform (health information technology, electronic prescribing, public health plans, comparative effectivness research, generic pharmaceuticals) Medicare Part D

LobbyistCovered position, as disclosed
JERRY STEFFL —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Centers For Medicare and Medicaid Services (CMS)

Bills named: H.R. 1548 (111th), H.R. 1427 (111th), H.R. 1204 (111th), H.R. 1 (111th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.